Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000950123-04-012534
Filing Date
2004-10-27
Accepted
2004-10-27 13:50:38
Documents
1
Effectiveness Date
2004-10-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS y68017dfan14a.txt DFAN14A 4837
  Complete submission text file 0000950123-04-012534.txt   6858
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: DFAN14A | Act: 34 | File No.: 001-12493 | Film No.: 041098997
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 225 E DEERPATH RD STE 250 LAKE FOREST IL 60045
Business Address 225 EAST DEERPATH RD SUITE 250 LAKE FOREST IL 60045 7704429707
KAPOOR JOHN N (Filed by) CIK: 0001033150 (see all company filings)